About UmanDiagnostics
UmanDiagnostics is a company based in Umea (Sweden) founded in 2006 was acquired by Quanterix in June 2019.. UmanDiagnostics offers products and services including NF-Light™ Serum ELISA assay, NF-Light™ CSF ELISA assays, and anti-NF-Light Antibodies. UmanDiagnostics operates in a competitive market with competitors including Cytox, ADx NeuroSciences, Amprion, PeopleBio R&D and Durin Technologies, among others.
- Headquarter Umea, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Umandiagnostics Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UmanDiagnostics
UmanDiagnostics offers a comprehensive portfolio of products and services, including NF-Light™ Serum ELISA assay, NF-Light™ CSF ELISA assays, and anti-NF-Light Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Quantifies Neurofilament light in serum for neurological injury detection.
Measures NF-L in CSF samples to detect neuronal damage.
Provides monoclonal antibodies for NF-L research applications.
Funding Insights of UmanDiagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UmanDiagnostics
UmanDiagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Quanterix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Assay kits for ultra-sensitive biomarker detection are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UmanDiagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UmanDiagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Umandiagnostics Comparisons
Competitors of UmanDiagnostics
UmanDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytox, ADx NeuroSciences, Amprion, PeopleBio R&D and Durin Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Prognostic tests for assessing dementia risk are developed.
|
|
| domain | founded_year | HQ Location |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| domain | founded_year | HQ Location |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| domain | founded_year | HQ Location |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Develops biomarkers and diagnostic tests for amyloid-related diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Umandiagnostics
Frequently Asked Questions about UmanDiagnostics
When was UmanDiagnostics founded?
UmanDiagnostics was founded in 2006.
Where is UmanDiagnostics located?
UmanDiagnostics is headquartered in Umea, Sweden.
What does UmanDiagnostics do?
UmanDiagnostics was founded in 2006 in Umea, Sweden, within the biotechnology sector focused on neurological diagnostics. Tools for early detection, treatment efficacy measurement, and disease progression monitoring are developed and marketed, with emphasis on white matter disorders such as multiple sclerosis and amyotrophic lateral sclerosis. The primary product, NF-light, is an ELISA assay enabling neurofilament light quantification in cerebrospinal fluid within three hours.
Who are the top competitors of UmanDiagnostics?
UmanDiagnostics's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.
What products or services does UmanDiagnostics offer?
UmanDiagnostics offers NF-Light™ Serum ELISA assay, NF-Light™ CSF ELISA assays, and anti-NF-Light Antibodies.
Who are UmanDiagnostics's investors?
UmanDiagnostics has 1 investor. Key investors include Quanterix.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.